Lysophospholipid acyltransferases: 1-acylglycerol-3-phosphate O-acyltransferases. from discovery to disease

Current Opinion in Lipidology

Volumn 23, Issue 4, 2012, Pages 290-302

  Agarwal, Anil K ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

acyltransferase; AGPAT; cancer; hepatic steatosis; lipodystrophy; LPAAT; phospholipids

Indexed keywords

1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE; 1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE 1; 1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE 10; 1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE 11; 1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE 2; 1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE 3; 1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE 4; 1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE 5; 1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE 6; 1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE 9; ACYLTRANSFERASE; CARDIOLIPIN; MYOGENIN; UNCLASSIFIED DRUG;

CATALYSIS; CRYSTAL STRUCTURE; ENDOPLASMIC RETICULUM; ENZYME ACTIVE SITE; FATTY ACID OXIDATION; GENE MUTATION; GENETIC ASSOCIATION; HOMOZYGOSITY; HUMAN; INSULIN RELEASE; MOLECULAR DOCKING; MOLECULAR INTERACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY CANCER; OXIDATIVE PHOSPHORYLATION; PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SECONDARY STRUCTURE; REVIEW; SEQUENCE HOMOLOGY; SPERMATID; SPERMATOCYTE; UPREGULATION;

1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE; 1-ACYLGLYCEROPHOSPHOCHOLINE O-ACYLTRANSFERASE; AMINO ACID SEQUENCE; ANIMALS; DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; ISOENZYMES; MOLECULAR SEQUENCE DATA;

MUS;

EID: 84863980291     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e328354fcf4     Document Type: Review

References (68)

1. Agarwal AK, Garg A. Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways. Trends Endocrinol Metab 2003; 14:214-221.
2. Coleman RA, Lee DP. Enzymes of triacylglycerol synthesis and their regulation. Prog Lipid Res 2004; 43:134-176.
3. Hajra AK, Larkins LK, Das AK, et al. Induction of the peroxisomal glycerolipidsynthesizing enzymes during differentiation of 3T3-L1 adipocytes. Role in triacylglycerol synthesis. J Biol Chem 2000; 275:9441-9446.
4. Agarwal AK, Arioglu E, De Almeida S, et al. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet 2002; 31:21-23.
5. Agarwal AK, Barnes RI, Garg A. Functional characterization of human 1-acylglycerol-3-phosphate acyltransferase isoform 8: cloning, tissue distribution, gene structure, and enzymatic activity. Arch Biochem Biophys 2006; 449:64-76.
6. Agarwal AK, Garg A. Enzymatic activity of the human 1-acylglycerol-3- phosphate-O-acyltransferase isoform 11: upregulated in breast and cervical cancers. J Lipid Res 2010; 51:2143-2152.
7. Agarwal AK, Sukumaran S, Bartz R, et al. Functional characterization of human 1-acylglycerol-3-phosphate-O-acyltransferase isoform 9: cloning, tissue distribution, gene structure, and enzymatic activity. J Endocrinol 2007; 193:445-457.
8. Agarwal AK, Sukumaran S, Cortes VA, et al. Human 1-acylglycerol-3- phosphate O-acyltransferase isoforms 1 and 2: biochemical characterization and inability to rescue hepatic steatosis in Agpat2(-/-) gene lipodystrophic mice. J Biol Chem 2011; 286:37676-37691.
9. Prasad SS, Garg A, Agarwal AK. Enzymatic activities of the human AGPAT isoform 3 and isoform 5: localization of AGPAT5 to mitochondria. J Lipid Res 2011; 52:451-462.
10. Sukumaran S, Barnes RI, Garg A, Agarwal AK. Functional characterization of the human 1-acylglycerol-3-phosphate-O-acyltransferase isoform 10/glycerol-3-phosphate acyltransferase isoform 3. J Mol Endocrinol 2009; 42:469-478.
11. Cao J, Shan D, Revett T, et al. Molecular identification of a novel mammalian brain isoform of acyl-CoA:lysophospholipid acyltransferase with prominent ethanolamine lysophospholipid acylating activity, LPEAT2. J Biol Chem 2008; 283:19049-19057.
12. Finn RD, Tate J, Mistry J, et al. The Pfam protein families database. Nucleic Acids Res 2008; 36:D281-D288.
13. Lewin TM, Wang P, Coleman RA. Analysis of amino acid motifs diagnostic for the sn-glycerol-3-phosphate acyltransferase reaction. Biochemistry 1999; 38:5764-5771.
14. Yamashita A, Nakanishi H, Suzuki H, et al. Topology of acyltransferase motifs and substrate specificity and accessibility in 1-acyl-sn-glycero-3- phosphate acyltransferase 1. Biochim Biophys Acta 2007; 1771:1202-1215.
15. Schmidt JA, Yvone GM, Brown WJ. Membrane topology of human AGPAT3 (LPAAT3). Biochem Biophys Res Commun 2010; 397:661-667.
16. Sharma A, Sharma A. Fatty acid induced remodeling within the human liver fatty acid-binding protein. J Biol Chem 2011; 286:31924-31928.
17. Subauste AR, Elliott B, Das AK, Burant CF. A role for 1-acylglycerol-3-phosphate-O-acyltransferase-1 in myoblast differentiation. Differentiation 2010; 80:140-146.
18. Agarwal AK, Simha V, Oral EA, et al. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J Clin Endocrinol Metab 2003; 88:4840-4847.
19. Agarwal AK, Garg A. Genetic basis of lipodystrophies and management of metabolic complications. Annu Rev Med 2006; 57:297-311.
20. Agarwal AK, Garg A. Genetic disorders of adipose tissue development, differentiation, and death. Annu Rev Genomics Hum Genet 2006; 7:175-199.
21. Cortes VA, Curtis DE, Sukumaran S, et al. Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophy. Cell Metab 2009; 9:165-176.
22. Gale SE, Frolov A, Han X, et al. A regulatory role for 1-acylglycerol-3-phosphate-O-acyltransferase 2 in adipocyte differentiation. J Biol Chem 2006; 281:11082-11089.
23. Koeberle A, Shindou H, Harayama T, et al. Polyunsaturated fatty acids are incorporated into maturating male mouse germ cells by lysophosphatidic acid acyltransferase 3. FASEB J 2012; 26:169-180.
24. Yuki K, Shindou H, Hishikawa D, Shimizu T. Characterization of mouse lysophosphatidic acid acyltransferase 3: an enzyme with dual functions in the testis. J Lipid Res 2009; 50:860-869.
25. Beltman ME, Forde N, Furney P, et al. Characterisation of endometrial gene expression and metabolic parameters in beef heifers yielding viable or nonviable embryos on Day 7 after insemination. Reprod Fertil Dev 2010; 22:987-999.
26. Beigneux AP, Vergnes L, Qiao X, et al. Agpat6-a novel lipid biosynthetic gene required for triacylglycerol production in mammary epithelium. J Lipid Res 2006; 47:734-744.
27. Vergnes L, Beigneux AP, Davis R, et al. Agpat6 deficiency causes subdermal lipodystrophy and resistance to obesity. J Lipid Res 2006; 47:745-754.
28. Thering BJ, Graugnard DE, Piantoni P, Loor JJ. Adipose tissue lipogenic gene networks due to lipid feeding and milk fat depression in lactating cows. J Dairy Sci 2009; 92:4290-4300.
29. Bouwman AC, Bovenhuis H, Visker MH, van Arendonk JA. Genomewide association of milk fatty acids in Dutch dairy cattle. BMC Genet 2011; 12:43.
30. He C, Wang C, Chang ZH, et al. AGPAT6 polymorphism and its association with milk traits of dairy goats. Genet Mol Res 2011; 10:2747-2756.
31. Chen YQ, Kuo MS, Li S, et al. AGPAT6 is a novel microsomal glycerol-3-phosphate acyltransferase. J Biol Chem 2008; 283:10048-10057.
32. Nagle CA, Vergnes L, Dejong H, et al. Identification of a novel sn-glycerol-3-phosphate acyltransferase isoform, GPAT4, as the enzyme deficient in Agpat6-/-mice. J Lipid Res 2008; 49:823-831.
33. Ye GM, Chen C, Huang S, et al. Cloning and characterization a novel human 1-acyl-sn-glycerol-3-phosphate acyltransferase gene AGPAT7. DNA Seq 2005; 16:386-390.
34. Cao J, Liu Y, Lockwood J, et al. A novel cardiolipin-remodeling pathway revealed by a gene encoding an endoplasmic reticulum-associated acyl-CoA:lysocardiolipin acyltransferase (ALCAT1) in mouse. J Biol Chem 2004; 279:31727-31734.
35. Zhao Y, Chen YQ, Li S, et al. The microsomal cardiolipin remodeling enzyme acyl-CoA lysocardiolipin acyltransferase is an acyltransferase of multiple anionic lysophospholipids. J Lipid Res 2009; 50:945-956.
36. Li J, Romestaing C, Han X, et al. Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity. Cell Metab 2010; 12:154-165.
37. Harayama T, Shindou H, Ogasawara R, et al. Identification of a novel noninflammatory biosynthetic pathway of platelet-activating factor. J Biol Chem 2008; 283:11097-11106.
38. Zou C, Ellis BM, Smith RM, et al. Acyl-CoA:lysophosphatidylcholine acyltransferase I (Lpcat1) catalyzes histone protein O-palmitoylation to regulate mRNA synthesis. J Biol Chem 2011; 286:28019-28025.
39. Bridges JP, Ikegami M, Brilli LL, et al. LPCAT1 regulates surfactant phospholipid synthesis and is required for transitioning to air breathing in mice. J Clin Invest 2010; 120:1736-1748.
40. Friedman JS, Chang B, Krauth DS, et al. Loss of lysophosphatidylcholine acyltransferase 1 leads to photoreceptor degeneration in rd11 mice. Proc Natl Acad Sci USA 2010; 107:15523-15528.
41. Morimoto R, Shindou H, Oda Y, Shimizu T. Phosphorylation of lysophosphatidylcholine acyltransferase 2 at Ser34 enhances platelet-activating factor production in endotoxin-stimulated macrophages. J Biol Chem 2010; 285:29857-29862.
42. Ghosh AK, Ramakrishnan G, Chandramohan C, Rajasekharan R. CGI-58, the causative gene for Chanarin-Dorfman syndrome, mediates acylation of lysophosphatidic acid. J Biol Chem 2008; 283:24525-24533.
43. Oberer M, Boeszoermenyi A, Nagy HM, Zechner R. Recent insights into the structure and function of comparative gene identification-58. Curr Opin Lipidol 2011; 22:149-158.
44. Cornaciu I, Boeszoermenyi A, Lindermuth H, et al. The minimal domain of adipose triglyceride lipase (ATGL) ranges until leucine 254 and can be activated and inhibited by CGI-58 and G0S2, respectively. PLoS One 2011; 6:e26349.
45. Demirkan A, van Duijn CM, Ugocsai P, et al. Genome-wide association study identifies novel loci associated with circulating phospho-and sphingolipid concentrations. PLoS Genet 2012; 8:e1002490.
46. Voight BF, Scott LJ, Steinthorsdottir V, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010; 42:579-589.
47. Sherva R, Baldwin CT, Inzelberg R, et al. Identification of novel candidate genes for Alzheimer's disease by autozygosity mapping using genome wide SNP data. J Alzheimers Dis 2011; 23:349-359.
48. Aporntewan C, Ballard DH, Lee JY, et al. Gene hunting of the Genetic Analysis Workshop 16 rheumatoid arthritis data using rough set theory. BMC Proc 2009; 3 (Suppl. 7):S126.
49. Toussirot E, Streit G, Wendling D. The contribution of adipose tissue and adipokines to inflammation in joint diseases. Curr Med Chem 2007; 14:1095-1100.
50. Arisi I, D'Onofrio M, Brandi R, et al. Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection. J Alzheimers Dis 2011; 24:721-738.
51. Xu Y, Shen Z, Wiper DW, et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA 1998; 280:719-723.
52. Baker DL, Morrison P, Miller B, et al. Plasma lysophosphatidic acid concentration and ovarian cancer. JAMA 2002; 287:3081-3082.
53. Pua TL, Wang FQ, Fishman DA. Roles of LPA in ovarian cancer development and progression. Future Oncol 2009; 5:1659-1673.
54. Sedlakova I, Vavrova J, Tosner J, Hanousek L. Lysophosphatidic acid (LPA)-a perspective marker in ovarian cancer. Tumour Biol 2011; 32:311-316.
55. Springett GM, Bonham L, Hummer A, et al. Lysophosphatidic acid acyltransferase-beta is a prognostic marker and therapeutic target in gynecologic malignancies. Cancer Res 2005; 65:9415-9425.
56. Diefenbach CS, Soslow RA, Iasonos A, et al. Lysophosphatidic acid acyltransferase-beta (LPAAT-beta) is highly expressed in advanced ovarian cancer and is associated with aggressive histology and poor survival. Cancer 2006; 107:1511-1519.
57. Tauber S, Jais A, Jeitler M, et al. Transcriptome analysis of human cancer reveals a functional role of heme oxygenase-1 in tumor cell adhesion. Mol Cancer 2010; 9:200.
58. Rastegar F, Gao JL, Shenaq D, et al. Lysophosphatidic acid acyltransferase beta (LPAATbeta) promotes the tumor growth of human osteosarcoma. PLoS One 2010; 5:e14182.
59. Huang RS, Duan S, Bleibel WK, et al. A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity. Proc Natl Acad Sci USA 2007; 104:9758-9763.
60. Zhou X, Lawrence TJ, He Z, et al. The expression level of lysophosphatidylcholine acyltransferase 1 (LPCAT1) correlates to the progression of prostate cancer. Exp Mol Pathol 2012; 92:105-110.
61. Mansilla F, da Costa KA, Wang S, et al. Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancer. J Mol Med (Berl) 2009; 87:85-97.
62. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-674.
63. Chiang AC, Massague J. Molecular basis of metastasis. N Engl J Med 2008; 359:2814-2823.
64. Kennedy EP, Weiss SB. The function of cytidine coenzymes in the biosynthesis of phospholipides. J Biol Chem 1956; 222:193-214.
65. Lands WE. Metabolism of glycerolipides; a comparison of lecithin and triglyceride synthesis. J Biol Chem 1958; 231:883-888.
66. Lands WE. Stories about acyl chains. Biochim Biophys Acta 2000; 1483: 1-14.
67. Shin JJ, Loewen CJ. Putting the pH into phosphatidic acid signaling. BMC Biol 2011; 9:85.
68. Ayciriex S, Le Guedard M, Camougrand N, et al. YPR139c/LOA1 encodes a novel lysophosphatidic acid acyltransferase associated with lipid droplets and involved in TAG homeostasis. Mol Biol Cell 2012; 23:233-246.